F. Hoffmann-La Roche Ltd

Overview

F. Hoffmann-La Roche Ltd (Roche) is a biotechnology company that develops drugs and diagnostics to treat major diseases. It provides pharmaceuticals for the treatment of cancer, other auto-immune diseases, central nervous system disorders, ophthalmological disorders, infectious diseases, and respiratory diseases. The company also offers in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. Roche conducts research to identify novel methods to prevent, diagnose and treat diseases. The company offers its products and services to hospitals, commercial laboratories, healthcare professionals, researchers, and pharmacists. Together with its subsidiaries and partners, the company has operations in various countries worldwide. Roche is headquartered in Basel, Switzerland.
Key Stats
Address
Grenzacherstr. 124, BASEL, Switzerland
Headquarters

Switzerland

Contact

41 9 732354295

Website
www.roche.com
No of Employees

101,465

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

ROG [SWF]

Revenue (2020)

$62,145 m

0.4% (2020 vs 2019)
Net Income (2020)

$15,232 m

12.1% (2020 vs 2019)
Net Profit Margin

25 %

11.6% (2020 vs 2019)
Market Cap *

$334,014 m

EPS *

$17.6

  *Note: Ratios based on the share price as of 11-June-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters F. Hoffmann-La Roche LtdJohnson & JohnsonNovartis AGMerck & Co Inc
Key Information
Headquarters Switzerland United States of America Switzerland United States of America
Headquarter City BASEL NEW BRUNSWICK BASEL KENILWORTH
Headquarter State/Province - New Jersey - New Jersey
No. of Employees 101,465 134,500 110,000 74,000
Entity Type Public Public Public Public
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age
Claudia Bockstiegel General Counsel Senior Management 2021 57
Jorg Duschmale Director Non Executive Board 2020 38
Non Dignissim Eros Proin vel Convallis 2015 XX
Non Dignissim Eros Proin vel Convallis 2015 XX
Non Dignissim Eros Proin vel Convallis 2015 XX
Non Dignissim Eros Proin vel Convallis 2015 XX

History

Year Event Description
2021 Regulatory Approval In April, the company secured FDA approval for VENTANA MMR RxDx Panel for advanced or…
2021 Regulatory Approval In January, the company secured the European Commission approval for its Xofluza for the treatment…
2021 Contracts/Agreements In January, the company entered into a collaboration with Cambridge Quantum Computing to design and…
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Genentech USA Inc

Address

1 DNA Way, South San Francisco
United States of America

Telephone

1 650 2251000

Website

www.gene.com
Hoffmann-La Roche Inc

Address

340 Kingsland Street, Nutley, Essex County
United States of America

Telephone

1 973 2355000

Roche Molecular Systems Inc

Address

4300 Hacienda Drive, Pleasanton
United States of America

Telephone

1 925 7308000

Website

www.diagnostics.roche.com
Roche (Hungary) Kft

Address

Edison, Budapest
Hungary

Telephone

36 23 446800

Website

www.roche.hu
Dutalys GmbH

Address

Muthgasse 11/2, Vienna
Austria

Telephone

43 1 9971832

Website

www.dutalys.com
Roche Holding, Ltd.

Address

Konzern-Hauptsitz, Grenzacherstrasse 124, Basel
Switzerland

Telephone

41 61 688 1111

Website

www.roche.ch
Jecure Therapeutics Inc

Address

Suite 150, 4757 Nexus Center Drive, San Diego
United States of America

Telephone

1 619 5418699

Website

www.jecuretx.com
Promedior Inc

Address

Suite 100, 81 Hartwell Avenue, Lexington
United States of America

Telephone

1 781 5384200

Website

www.promedior.com

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
04 Jun 2021 Surface Oncology Enters into Collaboration with Roche Partnership F. Hoffmann-La Roche Ltd; Surface Oncology Inc
27 May 2021 Disc Medicine Enters into Licensing Agreement with F. Hoffmann-La Roche Licensing Agreement Disc Medicine Inc F. Hoffmann-La Roche Ltd
26 May 2021 TransThera Biosciences Enters into Agreement with Roche Partnership TransThera Biosciences Co Ltd; F. Hoffmann-La Roche Ltd
06 May 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
15 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
27 Mar 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

1.5K

Active Jobs

597

Posted

1.2K

Closed

Job Trends

Latest Jobs

Job title Company Country
Content Creation & Strategy Lead, Digital Excellence F. Hoffmann-La Roche Ltd Switzerland
Solutions Support Partner - Services Engineer F. Hoffmann-La Roche Ltd Thailand
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar